BD (Becton, Dickinson and Company) a leading global medical technology company, announced the launch of the BD Surgiphor Surgical Wound Irrigation System in Europe. The system is the first of its kind to receive Conformité Européenne (CE) approval and is now available in select European countries.

Health Technology Insights: Voio Emerges From Stealth to Build Frontier AI for Healthcare

BD Surgiphor is a sterile, ready-to-use irrigation solution designed to help loosen and remove debris from surgical wounds during procedures. By flushing out debris and foreign materials, including microorganisms, it helps reduce the bacterial load that could lead to infection — a key factor associated with surgical site infections.

“This European launch marks a significant milestone in advancing surgical care,” said Rian Seger, worldwide president of BD Surgery. “Surgical Site Infections are multifactorial and continue to present serious challenges to both patient outcomes and healthcare systems. Surgiphor supports clinicians in implementing evidence-based practices — such as surgical wound irrigation — to help reduce risk, enhance recovery, and improve overall surgical safety.”

Health Technology Insights: GE Healthcare to Acquire Intelerad for Cloud Imaging Expansion

What makes Surgiphor different:

  • It’s pre-mixed and sterile, so hospitals don’t need to prepare it before surgery.
  • It uses a trusted antiseptic as preservative in the solution to help reduce bacterial load that could lead to infection.
  • The easy-to-handle design allows surgical teams to apply it quickly and precisely.

By simplifying surgical wound irrigation and reducing preparation time, Surgiphor helps hospitals operate more efficiently while supporting safer outcomes for patients. This launch reflects BD’s ongoing commitment to advancing surgical care through practical, proven solutions that put patient safety first. For more information, contact your BD sales rep.

Health Technology Insights: Sorcero Raises $42.5 Million to Scale Life Sciences AI

To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com

Source- PR Newswire